PharmAbcine Inc.

We strive to become a leading biotech company that contributes to human health and well-being by providing innovative therapeutic antibodies to patients with unmet medical needs. We have been committed to developing novel antibody therapeutics since the company was founded in 2008 and was successfully listed on KOSDAQ in 2018. Our goal is to focus on the development of novel antibody therapeutics and become a leading biotech company that contributes to human health and well-being.